EMEA-000525-PIP01-08-M08 - paediatric investigation plan
Amikacin sulfate
PIPHuman
Insmed Netherlands B.V.
E-mail: medicalinformation@insmed.com
Telephone: +1 9089474303
P/0107/2022 : EMA decision of 13 April 2022 on the acceptance of a modification of an agreed paediatric investigation plan for amikacin (sulfate) (Arikayce liposomal), (EMEA-000525-PIP01-08-M08)